ClinicalTrials.gg
CompletedNCT05365061Updated Jun 12, 2024

Periosteal Electrical Dry Needling for Knee Osteoarthritis

An interventional study of periosteal electrical dry needling with no maintenance treatments and periosteal electrical dry needling with maintenance treatments every other month in Knee Osteoarthritis, sponsored by Alabama Physical Therapy & Acupuncture. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-12.

Sponsored by Alabama Physical Therapy & Acupuncture · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Mar 2021, registered Apr 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
586
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to treat patients with knee osteoarthritis (OA) with periosteal electric dry needling (PEDN). It is also to determine the optimal "maintenance" regiment (i.e. maintenance treatments, one maintenance treatment every other month, or one maintenance treatment per month) required to maintain improvements in pain and function following PEDN. Physical therapists commonly use PEDN to treat knee OA, and previous studies suggest that this treatment is useful for reducing pain and improving function in patients with osteoarthritis. However, an appropriate maintenance treatment strategy to maintain these outcomes is presently unknown.

Read the detailed description

Patients with knee osteoarthritis will be randomized to receive periosteal electrical dry needling 1-2 treatments per week for 6 weeks (up to 10 sessions total) followed by either: 1. no maintenance treatments, 2. one maintenance treatment every other month or 3. one maintenance treatment per month.

02

Conditions studied

  • Knee Osteoarthritis
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's enrollment of 586 is above the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Alabama Physical Therapy & Acupuncture is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adult over the age of 18 years old:
  2. Report of knee pain of at least 2/10 per NPRS (0---10 scale) for >3 months
  3. Report of at least 3 of the following per Altman et al. (1986) (sensitivity = 95% / specificity = 69%)

    1. Over 50 Years of age
    2. Less than 30 minutes of morning stiffness
    3. Crepitus on active motion
    4. Bony tenderness
    5. Bony enlargement
    6. No palpable warmth of Synovium

Exclusion criteria

Exclusion Criteria:

  1. Report of red flags to manual physical therapy to include: hypertension, infection, diabetes, peripheral neuropathy, heart disease, stroke, chronic ischemia, edema, severe varicosities, tumor, metabolic disease, prolonged use, fracture, RA, osteoporosis, severe vascular disease, , etc.
  2. History of physical therapy, massage therapy, chiropractic treatment, or injections for knee pain in last 4 weeks.
  3. History of a partial or total knee replacement on the painful lower extremity.
  4. History of a surgical procedure on either lower extremity in last 12 months.
  5. Two or more positive neurologic signs consistent with nerve root compression, including any two of the following:

    1. Weakness involving a major muscle group of the lower extremity.
    2. Diminished patella or achilles tendon reflex
    3. Diminished or absent sensation to pinprick in lower extremity dermatome.
  6. Involvement in litigation or worker's compensation regarding knee pain.
  7. Any condition that might contraindicate the use of periosteal electric dry needling
  8. The patient is pregnant.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
586 participants (actual)

Study arms

  • Experimental
    Periosteal electrical dry needling followed by no maintenance treatments

    Periosteal electrical dry needling followed by no maintenance treatments

    Other: periosteal electrical dry needling with no maintenance treatments

  • Active comparator
    Periosteal electrical dry needling followed by maintenance treatments every other month

    Periosteal electrical dry needling followed by maintenance treatments every other month

    Other: periosteal electrical dry needling with maintenance treatments every other month

  • Active comparator
    Periosteal electrical dry needling followed by monthly maintenance treatments

    Periosteal electrical dry needling followed by monthly maintenance treatments

    Other: periosteal electrical dry needling with monthly maintenance treatments

Interventions

  • Otherperiosteal electrical dry needling with no maintenance treatments

    periosteal electrical dry needling

  • Otherperiosteal electrical dry needling with maintenance treatments every other month

    periosteal electrical dry needling with maintenance treatments every other month

  • Otherperiosteal electrical dry needling with monthly maintenance treatments

    periosteal electrical dry needling with monthly maintenance treatments

06

What researchers measure

Primary outcomes

  1. Change in WOMAC Knee Osteoarthritis Index (Total Score)

    24 questions each worth 0-4 points with maximum score of 96 points possible. The greater the score, the worse the symptoms of knee OA

    Time frame: baseline, 6 weeks, 14 weeks, 22 weeks, 30 weeks

Secondary outcomes

  1. Change in WOMAC Knee Osteoarthritis Index (Pain)

    5 questions each worth 0-4 points with maximum score of 20 points possible. The greater the score, the worse the pain.

    Time frame: baseline, 6 weeks, 14 weeks, 22 weeks, 30 weeks

  2. Change in WOMAC Knee Osteoarthritis Index (Stiffness)

    2 questions each worth 0-4 points with maximum score of 8 points possible. The greater the score, the worse the stiffness.

    Time frame: baseline, 6 weeks, 14 weeks, 22 weeks, 30 weeks

  3. Change in WOMAC Knee Osteoarthritis Index (Physical Function)

    17 questions each worth 0-4 points with maximum score of 68 points possible. The greater the score, the worse the physical function.

    Time frame: baseline, 6 weeks, 14 weeks, 22 weeks, 30 weeks

  4. Change in knee pain

    Average Numeric Pain Rating Score. Higher score means greater pain

    Time frame: baseline, 6 weeks, 14 weeks, 22 weeks, 30 weeks

  5. Change in GROC (Global Rating of Change score)

    GROC (ranges from -7 to +7). Global Rating of Change score

    Time frame: 6 weeks, 14 weeks, 22 weeks, 30 weeks

  6. Change in Medication Intake (Frequency of medication intake during last time period)

    Frequency of medication intake during last time period

    Time frame: baseline, 30 weeks

07

Study locations

1 site
  • Team Rehabilitation
    Chamblee, Georgia 30341, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in May 2024, 38 months.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 38 months is above that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2022
First posted
May 9, 2022
StartActual
Mar 1, 2021
Primary completionActual
May 1, 2024
CompletionActual
May 1, 2024
Last update
Jun 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05365061
Lead sponsor
Alabama Physical Therapy & Acupuncture
Responsible party
James Dunning, DPT, MSc, FAAOMPT (Principal Investigator, Alabama Physical Therapy & Acupuncture) — Principal investigator
First posted
May 9, 2022
Start date
Mar 1, 2021
Primary completion
May 1, 2024
Completion
May 1, 2024
Last update
Jun 12, 2024

Study contacts

James Dunning, PhD DPT
principal investigator · American Academy of Manipulative Therapy

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion